Heart Benefits of GLP-1 Medications Fade Shortly After Stopping Therapy | AJMC

Health Connectz5 months ago2 Views

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 exposure …

Source link

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Leave a reply

Loading Next Post...
Follow
Search
Popular Now
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

css.php